ArticleFrontiers in pharmacology2025
Association of genetically instrumented HMGCR inhibition with the therapeutic role of prostate cancer: a Mendelian randomization study and supporting
Xiaojie Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.